UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Biotransplant, Inc..
Common Stock, par value $.001 per share
(Title of Class of Securities)
(CUSIP Number: 09066Y107)
June 7, 2000
Date of event which requires filing
May 23, 2000
Check the appropriate box to designate the rule pursuant to which the schedule
is filed:
[ ] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be filled for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act,
but shall be subject to all other provisions of the Act (however, see the Notes
to Schedule 13G).
Page 1 of 15
<PAGE>
-------------------------------- ----------------------------
CUSIP No. 09066Y107 13G Page 2 of 10 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Paramount Capital Asset Management, Inc.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) (b)
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES None
BENEFICIALLY ------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH None
REPORTING ------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH None
------------------------------------------------
8 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
Page 2 of 15
<PAGE>
-------------------------------- ----------------------------
CUSIP No. 09066Y107 13G Page 3 of 10 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aries Domestic Fund, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) (b)
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES None
BENEFICIALLY ------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH None
REPORTING ------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH None
------------------------------------------------
8 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
Page 3 of 15
<PAGE>
-------------------------------- ----------------------------
CUSIP No. 09066Y107 13G Page 4 of 10 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Aries Domestic Fund II, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) (b)
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES None
BENEFICIALLY ------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH None
REPORTING ------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH None
------------------------------------------------
8 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
Page 4 of 15
<PAGE>
-------------------------------- ----------------------------
CUSIP No. 09066Y107 13G Page 5 of 10 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Aries Master Fund
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) (b)
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES None
BENEFICIALLY ------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH None
REPORTING ------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH None
------------------------------------------------
8 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO (see Item 2)
--------------------------------------------------------------------------------
Page 5 of 15
<PAGE>
-------------------------------- ----------------------------
CUSIP No. 09066Y107 13G Page 6 of 10 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Lindsay A. Rosenwald, M.D.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) (b)
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES None
BENEFICIALLY ------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH None
REPORTING ------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH None
------------------------------------------------
8 SHARED DISPOSITIVE POWER
None
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
Page 6 of 15
<PAGE>
ITEM 1(a). NAME OF ISSUER:
Biotransplant, Inc.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
Charlestown Navy Yard
Building 75
Third Avenue
Charlestown, MA 02129
(617) 241-5200
ITEM 2(a) NAME OF PERSON FILING:
This statement is filed on behalf of Paramount Capital Asset
Management, Inc. ("Paramount Capital"), Aries Domestic Fund, L.P.
("Aries Domestic"), Aries Domestic Fund II, L.P. ("Aries II"), Aries
Master Fund, a Cayman Island exempted company ("Aries Fund") and
Lindsay A. Rosenwald, M.D. ("Dr. Rosenwald" and collectively,
"Reporting Parties"). See attached Exhibit A which is a copy of their
agreement in writing to file this statement on behalf of each of them.
Dr. Rosenwald is an investment banker, venture capitalist, fund
manager and sole stockholder of Paramount Capital,(1) a Subchapter S
corporation incorporated in Delaware. Paramount Capital is the General
Partner to each of Aries Domestic,(2) and Aries Domestic II, limited
partnerships incorporated in Delaware. Paramount Capital is the
Investment Manager to Aries Fund,(3) a Cayman Islands exempted
company.
Dr. Rosenwald, Paramount Capital, Aries Domestic and Aries Fund and
their respective officers, directors, general partners, investment
managers, or trustees have not, during the five years prior to the
date hereof, been convicted in a criminal proceeding (excluding
traffic violations or similar misdemeanors).
ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
Paramount Capital's, Aries Domestic's, Aries II's, and Dr. Rosenwald's
business address is 787 Seventh Avenue, 48th Floor, New York, New
York, 10019. The business address for The Aries Fund is c/o
MeesPierson (Cayman) Limited, P.O. Box 2003, British American Centre,
Phase 3, Dr. Roy's Drive, George Town, Grand Cayman.
--------
(1) Please see attached Exhibit B indicating the executive officers and
directors of Paramount Capital and providing information called for by
Items 2-6 of this statement as to said officers and directors. Exhibit B
is herein incorporated by reference.
(2) Please see attached Exhibit C indicating the general partner to each of
Aries Domestic and Aries II and the general partner's executive officers
and directors and providing information called for by Items 2-6 of this
statement as to said general partners, officers and directors. Exhibit C
is herein incorporated by reference.
(3) Please see attached Exhibit D indicating the investment manager of the
Aries Fund and the investment manager's executive officers and directors
and providing information called for by Items 2-6 of this statement as to
said investment manager and officers and directors. Exhibit D is herein
incorporated by reference.
Page 7 of 15
<PAGE>
ITEM 2(c). CITIZENSHIP:
Dr. Rosenwald is a citizen of the United States of America.
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
ITEM 2(e). CUSIP NUMBER:09066Y107
ITEM 3. |X| CHECK THIS BOX IF THIS STATEMENT IS FILED PURSUANT TO RULE
13d-1(c)
ITEM 4. OWNERSHIP
For information concerning the ownership of Common Stock of the
Company by the Reporting Persons, see Items 5 through 9 and 11 of
the cover pages to this schedule 13G and footnotes thereto.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Reporting Person has ceased to be the beneficial owner of more than
five percent of a class of securities.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
a transaction having that purpose and effect.
Page 8 of 15
<PAGE>
Material to be Filed as Exhibits:
--------------------------------
Exhibit A - Copy of an Agreement between Dr. Rosenwald, Paramount Capital,
Aries Domestic and Aries Fund to file this Statement on Schedule 13G
on behalf of each of them.
Exhibit B - List of executive officers and directors of Paramount Capital and
information called for by Items 2-6 of this statement relating to
said officers and directors.
Exhibit C - List of executive officers and directors of Aries Domestic and
Aries II and information called for by Items 2-6 of this statement
relating to said officers and directors.
Exhibit D - List of executive officers and directors of Aries Fund and
information called for by Items 2-6 of this statement relating to
said officers and directors.
Page 9 of 15
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.
Dated: June 7, 2000
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
---------------------------------
Name: Lindsay A. Rosenwald, M.D.
Title: Chairman
ARIES DOMESTIC FUND, L.P.
By Paramount Capital Asset Management, Inc.,
General Partner
Dated: June 7, 2000
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
---------------------------------
Name: Lindsay A. Rosenwald, M.D.
Title: Chairman
ARIES DOMESTIC FUND, II L.P.
By Paramount Capital Asset Management, Inc.,
General Partner
Dated: June 7, 2000
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
---------------------------------
Name: Lindsay A. Rosenwald, M.D.
Title: Chairman
THE ARIES MASTER FUND
By Paramount Capital Asset Management, Inc.
Investment Manager
Dated: June 7, 2000
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
---------------------------------
Name: Lindsay A. Rosenwald, M.D.
Title:Chairman
Dated: June 7, 2000
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
---------------------------------
Name: Lindsay A. Rosenwald, M.D.
Title: Chairman
Page 10 of 15
